Alignment Healthcare, Inc.
Alignment Healthcare, Inc. (ALHC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
alhc · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Alignment Healthcare, Inc. (ALHC) measures how much investors pay for each dollar of the company's trailing earnings. ALHC's current PE ratio of 159.15x is calculated by dividing its stock price of $15.35 by its TTM earnings per share of $0.10.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2019 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Healthcare Plans · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Alignment Healthcare, Inc.You ALHC | $3.2B | 159.15x | -93.5% | $0.10 |
 Apogee Therapeutics, Inc. APGE | $5.1B | N/A | — | -$4.22 |
 Dyne Therapeutics, Inc. DYN | $2.8B | N/A | — | -$3.47 |
 GRAIL, Inc. GRAL | $2.6B | N/A | — | -$11.11 |
 ICU Medical, Inc. ICUI | $3.4B | 4802.44x | +96.8% | $0.03 |
 Mirum Pharmaceuticals, Inc. MIRM | $4.7B | N/A | — | -$0.47 |
 Envista Holdings Corp NVST | $3.8B | 77.60x | -96.8% | $0.28 |
Industry Average 2 peers with valid PE | — | 2440.02x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.00 | — | |
2024-12-31 FY2024 | — | $-0.67 | — | |
2023-12-31 FY2023 | — | $-0.79 | — | |
2022-12-31 FY2022 | — | $-0.83 | — | |
2021-12-31 FY2021 | — | $-1.14 | — | |
2020-12-31 FY2020 | — | $-0.12 | — | |
2019-12-31 FY2019 | — | $-0.29 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Alignment Healthcare, Inc. (ALHC) measures how much investors pay for each dollar of the company's trailing earnings. ALHC's current PE ratio of 159.15x is calculated by dividing its stock price of $15.35 by its TTM earnings per share of $0.10.
Frequently asked questions
ALHC pe ratio · 6 questionsALHC's current PE ratio is 159.15x as of 2026-06-08, based on a stock price of $15.35 and TTM EPS of $0.10. Data sourced from Financial Modeling Prep via ALHC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Alignment Healthcare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08